Prostaglandin E2 receptor modulation affects tumor cell adhesion to laminin

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Murine mammary adenocarcinoma cells synthesize prostaglandin E2 (PGE2) and possess a high-affinity PGE2 receptor.
• Modulating PGE2 synthesis or receptor function impacts tumor cell metastatic potential.
• Laminin and its receptors are crucial for cancer metastasis.

Purpose of the Study:

• To investigate if the PGE2 receptor influences tumor cell interactions with laminin.
• To determine the role of the PGE2 receptor in mediating mammary tumor cell attachment to laminin.

Main Methods:

• Utilized the 410.4 murine mammary tumor cell line and a laminin-derived peptide (PA22-2).
• Assessed tumor cell adhesion to laminin and PA22-2 in vitro.
• Tested the inhibitory effects of PGE receptor antagonists (LE0101, SC19220, sodium meclofenamate) on cell adhesion.
• Evaluated antagonist effects on a PGE receptor-negative cell line and adhesion to Type I collagen.

Main Results:

• Laminin and PA22-2 mediated attachment of 410.4 cells.
• PGE receptor antagonists significantly inhibited 410.4 cell attachment to laminin and PA22-2.
• LE0101 demonstrated potent, dose-dependent inhibition without causing toxicity.
• Antagonists had minimal effect on a PGE receptor-negative cell line and did not inhibit adhesion to Type I collagen.

Conclusions:

• The PGE2 receptor modulates mammary tumor cell adhesion to laminin.
• This modulation of tumor cell-laminin interactions may influence the metastatic process in vivo.
• Targeting the PGE2 receptor could represent a novel strategy for inhibiting cancer metastasis.